Skip to search.
New User?
Register
Sign in
Help
Get new Yahoo! Mail apps
Notifications
Help
Mail
My Y!
Yahoo!
Yahoo! Singapore Finance
Search
Search Web
Home
Investing
Volume Leaders
Singapore Indices
Currencies
US Indices
World Indices
Price Gainers
Price Losers
Forex and CFDs
News
Markets
Economy
Singapore
Technology
Property
Blogs
Photos
Video
My Portfolios
Sign in to access My Portfolios
Personal Finance
Investment
Career & Education
Insurance
Loans
Trading
Saving & Spending
Small Business
TechBizz
Search for share prices
Search for share prices
Wed, 19 Jun 2013, 15:01 SGT - Singapore Markets close in 1 hr 59 mins
STI
0.20%
More On ARNA
Quotes
Summary
Order Book
Options
Historical Prices
Charts
Interactive
Basic Chart
Basic Tech. Analysis
News & Info
Headlines
Company Events
Market Pulse
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Components
Analyst Coverage
Analyst Opinion
Analyst Estimates
Ownership
Major Holders
Insider Transactions
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
Arena Pharmaceuticals, Inc. (ARNA)
-
NasdaqGS
7.51
19 Jun 04:00 SGT
Add to Portfolio
Headlines
Get Headlines for:
Wednesday, June 19, 2013
American Medical Association Decision Can Boost Arena, Vivus, And Orexigen
at Seeking Alpha
(Wed, 12:22 SGT)
A.M.A. Recognizes Obesity as a Disease
at New York Times
(Wed, 06:09 SGT)
Tuesday, June 18, 2013
Consumer Reports Says "Exercise" Rather Than Take This Drug
at Motley Fool
(Tue, 18 Jun)
Monday, June 17, 2013
What Investors Need To Know About The Efficacy Of Belviq
at Seeking Alpha
(Mon, 17 Jun)
The Top 5 Diseases Caused by Obesity
at Motley Fool
(Mon, 17 Jun)
Friday, June 14, 2013
ARENA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a V
EDGAR Online
(Fri, 14 Jun)
BELVIQ® (lorcaserin HCl) CIV Data to be Presented at ENDO 2013
PR Newswire
(Fri, 14 Jun)
Arena Pharmaceuticals to Present at the 2013 Wells Fargo Securities Healthcare Conference
PR Newswire
(Fri, 14 Jun)
Arena Pharmaceuticals: A Trading Vehicle, At Best
at Seeking Alpha
(Fri, 14 Jun)
Arena's Belviq Does Not Fare Well With Consumer Reports
at Seeking Alpha
(Fri, 14 Jun)
More Reasons Arena Shorts May Have It Dead Wrong
at Seeking Alpha
(Fri, 14 Jun)
Wednesday, June 12, 2013
Why The Newest Short Thesis On Arena Is Dead Wrong And Should Be Ignored
at Seeking Alpha
(Wed, 12 Jun)
Pricing MannKind Corporation On A Stand-Alone Basis
at Seeking Alpha
(Wed, 12 Jun)
The Obesity-Drug Wars Officially Begin
at Motley Fool
(Wed, 12 Jun)
4 Healthcare Stock Stories For Thursday Inspection
at Wall St. Cheat Sheet
(Wed, 12 Jun)
[video] Arena Pharmaceuticals CEO on Belviq
at CNBC
(Wed, 12 Jun)
Arena Gets Price Target Raised To $12.50
at Seeking Alpha
(Wed, 12 Jun)
Analysts: Citigroup’s EPS Can Jump and 3 More Research Notes to Explore
at Wall St. Cheat Sheet
(Wed, 12 Jun)
An Obesity Drug Stock to Fatten your Portfolio?
at Motley Fool
(Wed, 12 Jun)
Friday, June 7, 2013
Weight loss drug Belviq gets overdue US launch
AP
(Fri, 7 Jun)
Older Headlines
View headlines from:
Friday, June 7, 2013
Friday, May 31, 2013
Friday, May 24, 2013
Friday, May 17, 2013
Friday, May 10, 2013
Friday, May 3, 2013
Friday, April 26, 2013
Friday, April 19, 2013
Friday, April 12, 2013
Friday, April 5, 2013
1187300158